Filing Analysis
📄 Other SEC Filing
Filed Sep 16, 2024
⚪ LOW
Pharma-Bio Serv, Inc. filed an 8-K to announce its results of operations for the three and nine months ended July 31, 2024.
📋 Key Facts
- Report date: September 16, 2024
- Reporting period: Three and nine months ended July 31, 2024
- The filing includes a press release (Exhibit 99.1) detailing financial results.
📄 Other SEC Filing
Filed Jun 14, 2024
⚪ LOW
Pharma-Bio Serv, Inc. filed an 8-K to announce its results of operations for the fiscal quarter ended April 30, 2024.
📋 Key Facts
- The filing is a standard announcement of quarterly results (Item 2.02).
- Reporting period: Quarter ended April 30, 2024.
- Filing date: June 14, 2024.
📄 Other SEC Filing
Filed May 02, 2024
⚪ LOW
Pharma-Bio Serv, Inc. held its 2024 Annual Meeting of Stockholders on May 2, 2024. The meeting resulted in the election of two directors and the ratification of the company's independent auditors.
🚩 Red Flags
- Dov Perlysky received a high number of 'Votes Withheld' (8,958,187) relative to his 'Votes For' (7,546,374), suggesting potential shareholder dissatisfaction or lack of confidence in this specific nominee.
📋 Key Facts
- Stockholders approved an amendment to extend the 2014 Long-Term Incentive Plan for ten additional years (until March 31, 2034).
- Kirk Michel was elected as a Class II director with 12,647,540 votes in favor.
- Dov Perlysky was elected as a Class II director with 7,546,374 votes in favor (noting significant withheld votes).
- Crowe PR PSC was ratified as the independent certified public accountants for the fiscal year ending October 31, 2024.
- The Plan Amendment received 7,523,008 votes in favor.
📄 Other SEC Filing
Filed Mar 18, 2024
⚪ LOW
Pharma-Bio Serv, Inc. filed an 8-K to announce its results of operations for the fiscal quarter ended January 31, 2024.
📋 Key Facts
- Report date: March 18, 2024
- Reporting period: Quarter ended January 31, 2024
- The filing consists of a press release (Exhibit 99.1) regarding financial results.
- Signed by Pedro J. Lasanta, CFO.
📄 Other SEC Filing
Filed Jan 30, 2024
⚪ LOW
Pharma-Bio Serv, Inc. filed an 8-K to announce its results of operations for the fiscal year ended October 31, 2023.
📋 Key Facts
- Reporting period: Fiscal year ended October 31, 2023.
- Announcement date: January 29, 2024.
- The filing includes a press release (Exhibit 99.1) detailing financial results.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.